US Edition#Innovations in RNA Medicine Stoke Therapeutics Highlights Path Forward in Dravet Syndrome at the Needham Conference
Summary by csimarket.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
#Innovations in RNA Medicine Stoke Therapeutics Highlights Path Forward in Dravet Syndrome at the Needham Conference
Stoke Therapeutics Showcases Groundbreaking Approach to RNA Medicine at 24th Annual Needham Virtual Healthcare Conference' In an exciting development for the field of biotechnology, Stoke Therapeutics, Inc. (Nasdaq: STOK) is set to present at the 24th Annual Needham Virtual Healthcare Conference. The company, headquartered in Bedford, Massachusetts, is making waves in the pharmaceutical industry with its focus on restoring protein expression thr…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
